Arsenic Trioxide Induces Erythroid Differentiation and Apoptosis of K562 Human Leukemia Cells through the Down-Regulation of Bcl-2
The Korean Journal of Hematology · 2005
DOI: 10.5045/kjh.2005.40.2.93 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Korean Journal of Hematology, 2005. Verfasst von Yong-Kyu You und 10 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Arsenic trioxide (As 2 O 3 ) has been identified as an effective drug for the treatment of acute promyelocytic leukemia (APL).However, the role of As 2 O 3 during the erythroid differentiation of human leukemic cells remains unknown.In this study, we investigated the in vitro effects of As 2 O 3 on the erythroid differentiation of the K562 cell line and also on the expression and regulation of the apoptotic modulators of this process.
Methods
The K562 cells were cultured in the presence of 0.1, 0.5 and 1.0μMAs 2 O 3 , or they were cultured in the presence of 1.0 and 10μM all trans retinoic acid (ATRA).The expression of glycophorin A before and after treatment with As 2 O 3 or with ATRA in the K562 cells was assessed by flow cytometry and western blotting.The expressions of Bcl-2 and caspase-3 were determined by western blotting. Results:The viability of the K562 cells was not decreased after treating with 0.1 and 0.5μM of As 2 O 3 , but the viability was significantly reduced at a dose of 1.0μM.Caspase 3 activation was not observed at 0.1 and 0.5μM of As 2 O 3 until 12 days, but Caspase 3 was activated by 1.0μM of As 2 O 3 from day 3.The expression of glycophorin A was increased in dose dependent manner by As 2 O 3 treatment, but this was not changed in the ATRA treated K562 cells.The expression of Bcl-2 was increased by 0.1 and 0.5μM of As 2 O 3 , but it was abruptly reduced by 1.0μM of As 2 O 3 .
Conclusion
These results suggest that As 2 O 3 induces the erythroid differentiation of K562 cells and that 1.0μM of As 2 O 3 induces apoptosis through the down-regulation of Bcl-2.(Korean J Hematol 2005; 40:93-100.)
Zitieren
APA
You, Y., Cheong, H., Won, J., Kim, S., Bae, S., Kim, C., Lee, N., Lee, K., Park, S., Hong, D., & Park, H. (2005). Arsenic Trioxide Induces Erythroid Differentiation and Apoptosis of K562 Human Leukemia Cells through the Down-Regulation of Bcl-2. The Korean Journal of Hematology. https://doi.org/10.5045/kjh.2005.40.2.93
Vancouver
You Y, Cheong H, Won J, Kim S, Bae S, Kim C, et al. Arsenic Trioxide Induces Erythroid Differentiation and Apoptosis of K562 Human Leukemia Cells through the Down-Regulation of Bcl-2. The Korean Journal of Hematology. 2005. doi:10.5045/kjh.2005.40.2.93
BibTeX
@article{You2005,
author = {You, Yong-Kyu and Cheong, Hee-Jeong and Won, Jong-Ho and Kim, Sook-Ja and Bae, Sang-Byung and Kim, Chan-Kyu and Lee, Nam-Su and Lee, Kyu-Taeg and Park, Sung-Kyu and Hong, Dae-Sik and Park, Hee-Sook},
title = {Arsenic Trioxide Induces Erythroid Differentiation and Apoptosis of K562 Human Leukemia Cells through the Down-Regulation of Bcl-2},
journal = {The Korean Journal of Hematology},
year = {2005},
doi = {10.5045/kjh.2005.40.2.93}
}
EUVIMED